Innovent Bio

IPO

Founded 2011 · $560.0M raised

Founded
2011
Business Model
B2B
Total Funding
$560.0M
Last Round
$5.0M Series A
Rounds
5

About

Innovent Biologics is a leading biopharmaceutical company founded in 2011 with the mission to provide high-quality biologics that are affordable to all. Through its hallmark integrated approach, state-of-the-art manufacturing facilities, and strategic collaborations, the company is involved in every stage of a drug's lifecycle, from discovery to development to commercialization, building robust pipelines for innovative drugs that treat cancer and other major diseases.

Summary

Innovent Bio is a Biotech company, founded in 2011. It has raised $560.0M in total across 5 rounds. Investors include F-Prime Capital, Eight Roads Ventures and Lilly Asia Ventures.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOVenture RoundOct 2018
$485.0M

Sign up to see all 6 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Innovent Bio on Indexed.vc
<a href="https://indexed.vc/companies/innovent-bio"><img src="https://indexed.vc/api/badge/company/innovent-bio" alt="Innovent Bio on Indexed.vc" width="260" height="76" /></a>